Murali Ramanathan

Murali Ramanathan.

Chief Compliance Officer

Ramanathan served as Director of Graduate Studies in the Pharmaceutical Sciences from 2008-2020 and oversaw the development of several new degree programs, curricular modernization, comprehensive program review and enrollment growth. He has been with the UB Department of Pharmaceutical Sciences since 1994.

Ramanathan's breadth of research spans between clinical, pharmaceutical, and computational sciences, with his clinical research focusing on multiple sclerosis: a neurological disease that causes physical and cognitive disability and whose etiology and pathogenesis remain poorly understood. He has made important contributions to understanding the role of environmental factors, particularly lipids in multiple sclerosis disease progression. His quantitative clinical pharmacology research focuses on using artificial intelligence to address clinical problems in neurodegenerative diseases and drug development. He received his Ph.D. in Bioengineering from the University of California, San Francisco, CA, M.S., and B.Tech. degrees in Chemical Engineering from Iowa State University, Ames, IA, and the Indian Institute of Technology, Kharagpur, India, respectively.